TownSquare Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-486
| Closed | -$239K | – | 293 |
|
|
2026
Q1 | $239K | Buy |
486
+20
| +4% | +$10.9K | 0.05% | 225 |
|
|
2025
Q4 | $270K | Sell |
466
-2,499
| -84% | -$1.41M | 0.06% | 207 |
|
|
2025
Q3 | $1.44M | Sell |
2,965
-4,633
| -61% | -$2.16M | 0.22% | 98 |
|
|
2025
Q2 | $3.08M | Sell |
7,598
-73,733
| -91% | -$30.8M | 0.3% | 74 |
|
|
2025
Q1 | $40.5M | Buy |
81,331
+2,999
| +4% | +$1.62M | 0.43% | 45 |
|
|
2024
Q4 | $40.8M | Sell |
78,332
-4,573
| -6% | -$2.51M | 0.46% | 41 |
|
|
2024
Q3 | $51.3M | Buy |
82,905
+3,447
| +4% | +$2.04M | 0.61% | 29 |
|
|
2024
Q2 | $43.9M | Buy |
79,458
+2,003
| +3% | +$1.15M | 0.6% | 32 |
|
|
2024
Q1 | $45M | Buy |
77,455
+27,534
| +55% | +$15.5M | 0.66% | 31 |
|
|
2023
Q4 | $26.5M | Sell |
49,921
-1,567
| -3% | -$758K | 0.45% | 49 |
|
|
2023
Q3 | $26.1M | Buy |
51,488
+1,422
| +3% | +$758K | 0.48% | 49 |
|
|
2023
Q2 | $26.1M | Buy |
50,066
+3,963
| +9% | +$2.14M | 0.48% | 50 |
|
|
2023
Q1 | $26.6M | Sell |
46,103
-951
| -2% | -$536K | 0.59% | 45 |
|
|
2022
Q4 | $25.9M | Buy |
47,054
+37,457
| +390% | +$19.8M | 0.64% | 37 |
|
|
2022
Q3 | $4.87M | Sell |
9,597
-302
| -3% | -$169K | 0.14% | 132 |
|
|
2022
Q2 | $5.38M | Buy |
9,899
+208
| +2% | +$114K | 0.15% | 119 |
|
|
2022
Q1 | $5.72M | Buy |
9,691
+221
| +2% | +$127K | 0.15% | 133 |
|
|
2021
Q4 | $6.32M | Buy |
9,470
+106
| +1% | +$66.2K | 0.16% | 114 |
|
|
2021
Q3 | $5.35M | Buy |
9,364
+335
| +4% | +$184K | 0.15% | 122 |
|
|
2021
Q2 | $4.67M | Buy |
9,029
+300
| +3% | +$142K | 0.15% | 121 |
|
|
2021
Q1 | $3.98M | Buy |
8,729
+94
| +1% | +$44.9K | 0.15% | 119 |
|
|
2020
Q4 | $4.02M | Sell |
8,635
-113
| -1% | -$53K | 0.18% | 109 |
|
|
2020
Q3 | $3.9M | Sell |
8,748
-1,316
| -13% | -$544K | 0.23% | 89 |
|
|
2020
Q2 | $3.81M | Buy |
10,064
+108
| +1% | +$36.2K | 0.26% | 77 |
|
|
2020
Q1 | $3.28M | Sell |
9,956
-1,285
| -11% | -$405K | 0.27% | 72 |
|
|
2019
Q4 | $3.65M | Buy |
11,241
+363
| +3% | +$110K | 0.3% | 69 |
|
|
2019
Q3 | $3.19M | Buy |
10,878
+479
| +5% | +$137K | 0.26% | 80 |
|
|
2019
Q2 | $2.86M | Sell |
10,399
-5,544
| -35% | -$1.53M | 0.27% | 74 |
|
|
2019
Q1 | $4.36M | Buy |
15,943
+9,213
| +137% | +$2.29M | 0.34% | 71 |
|
|
2018
Q4 | $1.66M | Buy |
+6,730
| New | +$1.58M | 0.22% | 91 |
|
Other funds holding TMO
TownSquare Capital's TMO Position: Q2 2026 in Review
TownSquare Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 486 shares — an estimated $239K sold.
TownSquare Capital first reported a position in TMO in Q4 2018 and held it in 30 quarters. The position peaked at $51.3M in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- TownSquare Capital reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
- TownSquare Capital sold 486 Thermo Fisher Scientific shares in Q2 2026, an estimated $239K.
- TownSquare Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 30 quarters.
- TownSquare Capital's Thermo Fisher Scientific position peaked at $51.3M in Q3 2024.
- 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on TownSquare Capital's 13F filing for Q2 2026, filed 14 Aug 2026.